Nicotine Treatment of Mild Cognitive Impairment (MCI) - Contacts and Locations

Nicotine Treatment of Mild Cognitive Impairment (MCI)

This study is ongoing, but not recruiting participants.

Study NCT00091468. Last updated on January 7, 2008. Information provided by National Institute on Aging (NIA)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00091468

Locations


United States, District of Columbia
	Georgetown University Medical Center, Department of Neurology
	Washington, District of Columbia, United States, 20057

United States, North Carolina
	Duke University, Duke Health Center at Morreene Road
	Durham, North Carolina, United States, 27705

United States, Vermont
	University of Vermont College of Medicine
	Burlington, Vermont, United States, 05401

Sponsors and Collaborators

National Institute on Aging (NIA)

Investigators


Principal Investigator:	Paul Newhouse, MD	University of Vermont